Lateralization After IntraMedullary Nailing of InterTrochanteric Hip Fractures, Clinical and Radiographic Outcomes
NCT ID: NCT05094791
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2021-10-04
2024-02-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Helical Blade vs Lag Screw Fixation for Cephalomedullary Nailing of Low Energy Intertrochanteric Hip Fractures
NCT04306198
Blade vs Screw Intertrochanteric Hip Fracture Fixation Study
NCT03491189
Intramedullary Nailing of the Femur:Trochanteric vs Piriformis Starting Portals
NCT00593333
Intertrochanteric Femoral Fracture Fixation Trial
NCT02627040
Does an Additional Antirotation U-Blade (RC) Lagscrew Improve Treatment of AO/OTA (Orthopaedic Trauma Association) 31 A1-3 Fractures With Gamma 3 Nail?
NCT02657902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telescoping Lag Screw
Intertrochanteric fractures treated with Arthrex Hip Nail with Telescoping Screw
Telescoping Lag Screw
Intertrochanteric fracture fixation using Arthrex Hip Nail with Telescoping Lag Screw
Standard lag Screw
Intertrochanteric fractures treated with Zimmer Natural Nail Cephalomedullary Nail
Standard lag Screw
Intertrochanteric fracture fixation using Zimmer Natural Nail Cephalomedullary Nail using standard lag screw
Standard lag screw with addition of worm screw
Intertrochanteric fractures treated with Smith and Nephew TRIGEN INTERTAN
Standard lag screw with addition of worm screw
Intertrochanteric fracture fixation using Smith and Nephew TRIGEN INTERTAN with addition of worm screw
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telescoping Lag Screw
Intertrochanteric fracture fixation using Arthrex Hip Nail with Telescoping Lag Screw
Standard lag Screw
Intertrochanteric fracture fixation using Zimmer Natural Nail Cephalomedullary Nail using standard lag screw
Standard lag screw with addition of worm screw
Intertrochanteric fracture fixation using Smith and Nephew TRIGEN INTERTAN with addition of worm screw
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluoroscopic views of the final fixation construct or a post-operative radiograph taken within 24 hours must be available.
Exclusion Criteria
* Cognitive deficiencies that prevent the patient from providing their own informed consent
* Inability to follow-up at the discretion of the investigator (incarceration, moving out of area, no permanent housing)
* Prior fracture to injured hip
* Prior surgery to injured hip
* Basi-cervical fracture pattern (fracture that begins above the lesser trochanter and exits medial to the greater trochanter)
* Patients not treated within 48 hours of admission
* Chronic or acute infection at site of surgery
* Language barrier preventing completion of study forms in English
* Open fracture
* Fracture related to neoplasm
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arthrex, Inc.
INDUSTRY
Prisma Health-Upstate
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John D Adams, MD
Role: PRINCIPAL_INVESTIGATOR
Prisma Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Greenville Memorial Hosptial
Greenville, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00113048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.